Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hamartoma”

141 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 141 results

Large-scale testing (Phase 3)Study completedNCT00789828
What this trial is testing

Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)

Who this might be right for
Tuberous SclerosisSubependymal Giant Cell Astrocytoma
Novartis Pharmaceuticals 117
Post-approval studies (Phase 4)Ended earlyNCT01266291
What this trial is testing

Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients

Who this might be right for
Complex Partial Seizures
University of Pennsylvania 1
Not applicableLooking for participantsNCT05485831
What this trial is testing

Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY

Who this might be right for
Lennox Gastaut SyndromeDravet SyndromeTuberous Sclerosis Complex
Jazz Pharmaceuticals 100
Early research (Phase 1)Looking for participantsNCT07369505
What this trial is testing

Sapu003 in Advanced mTOR-sensitive Solid Tumors

Who this might be right for
Breast Cancer MetastaticRenal Cell Carcinoma (RCC)Neuroendocrine Tumors+2 more
SAPU NANO (US) LLC 27
Testing effectiveness (Phase 2)Study completedNCT00411619
What this trial is testing

Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex

Who this might be right for
Tuberous SclerosisSubependymal Giant Cell Astrocytoma
Children's Hospital Medical Center, Cincinnati 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07287202
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME)

Who this might be right for
Focal Cortical DysplasiaTuberous Sclerosis Complex (TSC)Hemimegalencephaly
Sovargen 15
Not applicableEnrolling By InvitationNCT03836300
What this trial is testing

Parent and Infant Inter(X)Action Intervention (PIXI)

Who this might be right for
Fragile X SyndromeAngelman SyndromePrader-Willi Syndrome+11 more
RTI International 120
Testing effectiveness (Phase 2)Study completedNCT02849457
What this trial is testing

Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex

Who this might be right for
Tuberous Sclerosis Complex
Martina Bebin 84
Post-approval studies (Phase 4)Study completedNCT03525834
What this trial is testing

Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.

Who this might be right for
Renal Angiomyolipoma
Novartis Pharmaceuticals 40
Not applicableNo Longer AvailableNCT03317366
What this trial is testing

Expanded Access to Provide ARQ 092 for the Treatment of Overgrowth Diseases and/or Vascular Anomalies

Who this might be right for
Proteus SyndromePIK3CA-Related Overgrowth Spectrum (PROS)Growth Disorders
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Post-approval studies (Phase 4)Active Not RecruitingNCT05252585
What this trial is testing

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

Who this might be right for
Renal Angiomyolipoma
Novartis Pharmaceuticals 4
Not applicableStudy completedNCT03680924
What this trial is testing

Access to Resources for Patients With PTEN Hamartoma Tumor Syndrome

Who this might be right for
PTEN Gene Mutation
University of South Florida 13
Large-scale testing (Phase 3)Study completedNCT02544763
What this trial is testing

Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

Who this might be right for
Tuberous Sclerosis ComplexSeizures
Jazz Pharmaceuticals 224
Large-scale testing (Phase 3)Looking for participantsNCT05534672
What this trial is testing

Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex

Who this might be right for
Tuberous Sclerosis Complex
Katarzyna Kotulska 200
Testing effectiveness (Phase 2)Study completedNCT05626634
What this trial is testing

Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy

Who this might be right for
Developmental and Epileptic EncephalopathyDravet SyndromeLennox-Gastaut Syndrome
Longboard Pharmaceuticals 41
Large-scale testing (Phase 3)Study completedNCT03140449
What this trial is testing

Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis

Who this might be right for
Facial Angiofibroma
National Taiwan University Hospital 52
Not applicableLooking for participantsNCT01247597
What this trial is testing

DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study

Who this might be right for
Pleuropulmonary BlastomaCystic NephromaOvarian Sertoli-Leydig Cell Tumors+2 more
National Cancer Institute (NCI) 1,500
Testing effectiveness (Phase 2)Study completedNCT03650452
What this trial is testing

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

Who this might be right for
EpilepsyDravet SyndromeLennox-Gastaut Syndrome
Takeda 141
Large-scale testing (Phase 3)Study completedNCT05495425
What this trial is testing

Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC

Who this might be right for
Tuberous Sclerosis Complex
Nobelpharma 43
Not applicableLooking for participantsNCT06523582
What this trial is testing

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Who this might be right for
Neuroendocrine NeoplasmNeuroendocrine Neoplasm of Gastrointestinal TractNeuroendocrine Neoplasm of Lung+23 more
Universidad Nacional Autonoma de Mexico 750
Load More Results